세계 유방 재건 시장 규모는 2023년 5억 5,450만 달러, 2030년까지 8억 1,014만 달러로 2024-2030년의 예측 기간 동안 6.54%의 연평균 복합 성장률(CAGR)을 나타낼 것으로 예상됩니다. 유방암 유병률 증가, 미용 및 재건 수술 건수 증가, 첨단 기술을 활용한 유방 재건 제품 출시 급증, 고령화, 인종, 민족 등의 요인이 유방 재건 수요를 촉진하고 있으며, 이로 인해 시장은 긍정적인 성장을 보이고 있습니다. 따라서 유방 재건 시장은 2024-2030년의 예측 기간 동안 상당한 CAGR로 성장할 것으로 예상됩니다.
유방 재건 시장 역학
유방 재건 시장의 주요 촉진요인 중 하나는 세계 유방암 유병률 증가로, 2023년에 발표된 세계보건기구(WHO) 데이터에 따르면 2020년 전 세계 230만 명의 여성이 유방암 진단을 받았다고 합니다. 같은 자료에 따르면 2020년 말까지 지난 5년간 780만 명의 여성이 유방암 진단을 받아 세계에서 가장 흔한 질병이 되었습니다고 합니다.
또 다른 유방 재건 시장의 성장을 이끄는 또 다른 주요 요인은 전 세계적으로 미용 성형 및 재건 수술 건수 증가입니다. 예를 들어, Plastic Surgery Statistics Report(2020)에 따르면 2020년에 미국에서 시행된 미용 성형 수술은 총 1,560만 건으로, 그 중 미용 수술은 230만 건, 최소 침습 수술은 1,320만 건으로 집계됐습니다. 같은 자료에 따르면 2020년에 680만 건의 재건 수술이 이루어졌습니다(2019년 대비 3% 증가). 또한 2020년 미국에서는 19만 3,073건의 유방 확대 수술이 진행되었으며, 이 중 84%는 실리콘 보형물을 사용했고 16%는 식염수 보형물을 사용했습니다. 따라서 미용 및 재건 수술이 증가함에 따라 유방 재건에 대한 수요도 증가하여 전체 유방 재건 시장의 성장을 가속할 것입니다.
따라서, 위의 모든 요인들이 결합하여 2024-2030년의 예측 기간 동안 유방 재건 시장의 전반적인 성장을 가속할 것으로 예상됩니다.
그러나 대체 비수술적 방법의 가용성과 보형물을 이용한 유방 재건술의 높은 비용은 세계 유방 재건 시장의 성장을 저해할 것으로 예상됩니다.
코로나19 팬데믹이 진행되면서 코로나19 환자에 비해 암 및 기타 질환을 앓고 있는 환자의 입원 및 선택적 수술이 우선순위에서 밀려나면서 유방 재건 시장에 부정적인 영향을 미치고 있습니다. 봉쇄 조치, 인력 부족, 마스크 및 PPE 키트 부족은 유방 재건 수술 환자의 입원에 큰 영향을 미쳤습니다. 그러나 대중의 예방접종, 봉쇄 규제 완화, 선택적 수술 재개, 마스크, PPE 키트 및 직원의 가용성으로 인해 유방 재건 시장은 모멘텀을 되찾고 2024-2030년의 예측 기간 동안 성장할 것으로 예상됩니다.
유방 재건 시장 부문별 분석
유방 재건 시장의 제품 유형 부문에서는 유방 보형물이 2023년에 가장 큰 매출 점유율을 차지할 것으로 예상됩니다. 유방 재건 시장의 주요 성장 동력은 전 세계 여성들의 심미적 매력을 향상시키는 유방 보형물에 대한 수요 증가 등입니다. 유방 재건 수술은 흉벽의 선천적 결함이나 기형을 치료하고 유방의 모양과 크기를 변경하는 데 사용됩니다. 또한 유방 재건 수술은 유방 절제술 후 자연스러운 모양의 유방을 복원하거나 단순히 유방을 확대하는 데 도움이되며 유방에 지방 조직이 많지 않은 사람들에게 좋은 선택이며 유방에 볼륨뿐만 아니라 곡선을 추가하는 데 도움이 됩니다.
따라서, 유방 재건에 사용되는 유방 보형물과 관련된 이점은 시장 수요를 증가시키고 예측 기간 동안 전체 유방 재건 시장의 성장을 가속할 것입니다. 또한, 유방 재건 제품에 대한 규제 당국의 승인 증가도 시장 성장을 가속하는 요인으로 작용하고 있습니다. 예를 들어, 2020년 9월, 세계 최고의 유방 미용 기업이자 Johnson & Johnson Medical Devices의 자회사인 Mentor Worldwide LLC는 미국 식품의약국(FDA)으로부터 22세 이상 여성의 유방 보형물 및 모든 연령대의 여성 유방 재건용, MENTOR® MemoryGel BOOSTTM 유방 보형물을 승인했다고 발표했습니다.
이 보고서는 세계 유방 재건 시장에 대해 조사 분석했으며, 시장 규모와 예측, 촉진요인 및 과제, 기업 및 제품 프로파일 등의 정보를 제공합니다.
Breast Reconstruction Market By Product Type (Breast Implants, Breast Expanders, And Acellular Dermal Matrix), By Shape (Round And Anatomical), By End-User (Hospitals, Cosmetology Clinics, And Ambulatory Surgical Centers), and by geography is expected to grow at a steady CAGR forecast till 2030 owing to the increasing prevalence of breast cancer and the increase in the number of cosmetic & reconstructive plastic surgeries
The global breast reconstruction market was valued at USD 554.50 million in 2023, growing at a CAGR of 6.54% during the forecast period from 2024 to 2030 to reach USD 810.14 million by 2030. The breast reconstruction market is witnessing positive growth owing to various factors such as the increasing prevalence of breast cancer, the increase in the number of cosmetic & reconstructive surgeries, the surge in the launch of technologically advanced breast reconstruction products, and the factors such as aging, race, & ethnicity drives the breast reconstruction demand. Therefore, the market for breast reconstruction is estimated to grow at a significant CAGR during the forecast period from 2024 to 2030.
Breast Reconstruction Market Dynamics:
One of the main drivers of the breast reconstruction market is the increasing prevalence of breast cancer globally. According to World Health Organization (WHO) data published in the year 2023, 2.3 million women worldwide were diagnosed with breast cancer in 2020. As per the same source mentioned above, by the end of 2020, 7.8 million women were diagnosed with breast cancer in the previous five years, making it the most common disease in the world.
Moreover, another key factor that is responsible for the growth of the breast reconstruction market is the increase in the number of cosmetic & reconstructive surgeries across the globe. For instance, according to the plastic surgery statistics report 2020, in America, there were 15.6 million total cosmetic procedures performed in the year 2020, of which 2.3 million were cosmetic surgical procedures and 13.2 million cosmetic procedures were minimally invasive. As per the same source, 6.8 million reconstructive procedures were performed in the year 2020 (a 3% increase from 2019). Further, in the year 2020, in America, there were 193,073 breast augmentations performed, of which silicone implants were utilized in 84% while saline implants were used in 16%. Therefore, with the increase in cosmetic & reconstructive surgeries, demand for breast reconstruction also increases, thereby driving the breast reconstruction overall market growth.
Therefore, all the factors mentioned above will collectively surge the overall growth of the breast reconstruction market during the forecast period from 2024-2030.
However, availability of the alternative non-surgical methods and the high cost of breast reconstruction using implants will hamper the global breast reconstruction market growth.
The ongoing Coronavirus disease 2019 (COVID-19) pandemic has negatively impacted the market for breast reconstruction as hospital admissions for patients suffering from cancers & other disorders as well as elective surgeries were not a priority in comparison to the patients suffering from COVID. Lockdown restrictions, lack of staff, and shortage of masks, and PPE kits made a huge impact on patient admissions in hospitals for breast reconstruction. However, with masses being vaccinated, lockdown restriction relaxation, resumption of elective surgeries, and availability of masks, PPE kits, and staff, the breast reconstruction market has picked momentum and is expected to grow during the forecast period from 2024-2030.
Breast Reconstruction Market Segment Analysis:
Breast Reconstruction Market by Product Type (Breast Implants, Breast Expanders, and Acellular Dermal Matrix), Shape (Round and Anatomical), End-User (Hospitals, Cosmetology Clinics, and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the by-product type segment of the breast reconstruction market, breast implants are expected to hold a significant revenue share in the year 2023. The key attributes driving the growth of the breast reconstruction market includes the rising demand of breast implants among the women across the globe as to enhance their aesthetic appeal. Breast reconstructive surgery address congenital defects and deformities of the chest wall, it is also used to change shape as well as size of the breast. Further, breast reconstructive surgery also helps to restore a natural-looking breast following a mastectomy, or simply to enlarge the breasts and it's a good alternative for people who don't have a lot of fatty tissue on breast, and adds volume as well as curves to the breast.
Therefore, the benefits associated with breast implants for breast reconstruction would increase their demand in the market, which will drive the growth of the overall breast reconstruction market during the forecast period. Further, the increase in the regulatory approvals for breast reconstruction products is also driving market growth. For instance, in September 2020, Mentor Worldwide LLC, the world's leading breast aesthetics company and a subsidiary of Johnson & Johnson Medical Devices, announced that the US Food and Drug Administration (FDA) has approved the MENTOR® MemoryGel BOOSTTM breast implant for breast augmentation in women over the age of 22 and for breast reconstruction in women of all ages.
Therefore, such type of development activities in the breast implant segment for breast reconstruction would result in driving the demand for breast reconstruction which in turn would provide a conductive growth for the overall breast reconstruction market during the forecast 2024-2030.
North America is expected to dominate the overall Breast Reconstruction Market:
Among all the regions, North America is expected to dominate the global breast reconstruction market in the year 2023 and is expected to do the same during the forecast period from 2024-2030. Factors such as aging, race, and ethnicity drive breast reconstruction demand, and the surge in the launch of technologically advanced breast reconstruction products are expected to increase the demand for breast reconstructions in the North America market.
According to the American Cancer Society data published in January 2022, breast cancer rates vary between racial and ethnic groupings in the United States. According to the latest statistics, black women are diagnosed at a younger age (60) than white women (63), and they have a higher death rate. This might be because one in every five black women has triple-negative breast cancer, which is greater than any other racial/ethnic group. As per the source mentioned above, black women have a significant risk of having cancer before the age of 40 years.
Furthermore, the most significant risk factor for breast cancer is age. People's risks of having cancer increase as they grow older. According to the American Cancer Society, data published in the year 2023, in the United States, one out of every eight women under the age of 45 will acquire invasive breast cancer by the end of the year 2022, and two out of every three invasive breast cancers will be diagnosed in women 55 and older.
Moreover, according to the Breast Cancer Organization data published in the year 2023, more than 3.8 million women in the United States had a history of breast cancer as of January 2022. As per the aforementioned source, by the end of the year 2022, 2,710 additional instances of invasive breast cancer in men are predicted to be detected.
Additionally, another factor such as the surge in the launch of technologically advanced breast reconstruction products will also drive the breast reconstruction market. For instance, in May 2022, GC Aesthetics Inc., a privately-held medical technology company providing aesthetic solutions, announced the launch of its next-generation breast implants, PERLE(TM). It is a highly innovative line of smooth breast implants that features a proprietary surface technology (BioQ(TM)), GCA's industry-leading gel technology (Emunomic(TM) Breast Tissue Dynamic Gel), and an improved version of the safety measures that have underpinned GCA's long-term excellent safety record.
Therefore, the interplay of the factors mentioned above for breast reconstruction would provide a conducive growth environment for the North American region in the breast reconstruction market.
Breast Reconstruction Market Key Players:
Some of the key market players operating in the breast reconstruction market include Mentor Worldwide LLC, AbbVie Inc, IDEAL IMPLANT INCORPORATED, Sebbin, GC Aesthetics, POLYTECH Health & Aesthetics GmbH, Sientra Inc, Integra LifeSciences, Establishment Labs S.A, LABORATOIRES ARION, HansBioMed, Lattice Medical, CEREPLAS, AirXpanders, PMT Corporation, SILIMED, DPS Technology Development Ltd, Technomed (India) Private Limited, Apex Medical Device Design LLC (DefyGravity), Guangzhou Wanhe Plastic Material Co Ltd and among others
Recent Developmental Activities in the Breast Reconstruction:
In September 2020, POLYTECH Health & Aesthetics GmbH, a global pioneer in breast aesthetics, expanded its B-Lite® portfolio, which includes the world's first and only lightweight breast implants. B-Lite® breast implants offer several benefits to women, including faster recovery & less post-operative discomfort, allowing patients to return to their normal routine sooner. B-Lite® with MESMO® fine-texturing surface and B-Lite® with the distinctive Microthane® shell coating are among the new forms and surfaces in the enlarged offering
In August 2020, Sientra, Inc, a diversified global medical aesthetics company, announced the approval from Japan's Pharmaceutical and Medical Device Agency ("PDMA") to market its entire OPUS line of breast implants in Japan.
In November 2019, BellaSano, German additive manufacturing start-up signed a long term agreement with Evonik, a chemical company's RESOMER bioresorbable polymer to create a new breast implant technology. RESOMER will be used in BellaSeno's 3D-printed Senella breast scaffold. The product is intended to be used for breast reconstruction, augmentation, and revision surgery. As it is gradually absorbed by the body and the natural breast tissue replaces it.
Key Takeaways from the Breast Reconstruction Market Report Study:
Target Audience who can be benefited from this Breast Reconstruction Market Report Study
Frequently Asked Questions for Breast Reconstruction:
Breast reconstruction is a surgical procedure that reconstructs the form and appearance of a breast, most often in women who have had breast cancer surgery. The objective is to rebuild a natural-looking breast utilizing autologous tissue, artificial implants, or a mix of both.
The global breast reconstruction market was valued at USD 554.50 million in 2023, growing at a CAGR of 6.54% during the forecast period from 2024 to 2030 to reach USD 810.14 million by 2030.
The breast reconstruction market is witnessing positive market growth owing to the factors such as, such as the increasing prevalence of breast cancer, the increase in the number of cosmetic & reconstructive surgeries, the surge in the launch of technologically advanced breast reconstruction products, and the factors such as aging, race, & ethnicity will also contribute in the growth of breast cancer which drives the breast reconstruction product demand.
Some of the key market players operating in the breast reconstruction market include Mentor Worldwide LLC, AbbVie Inc, IDEAL IMPLANT INCORPORATED, Sebbin, GC Aesthetics, POLYTECH Health & Aesthetics GmbH, Sientra Inc, Integra LifeSciences, Establishment Labs S.A, LABORATOIRES ARION, HansBioMed, Lattice Medical, CEREPLAS, AirXpanders, PMT Corporation, SILIMED, DPS Technology Development Ltd, Technomed (India) Private Limited, Apex Medical Device Design LLC (DefyGravity), Guangzhou Wanhe Plastic Material Co Ltd and among others.
North America is expected to dominate the global breast reconstruction market. Factors contributing to the growth are the surge in the launch of technologically advanced breast reconstruction products, and the factors such as aging, race, & ethnicity drive the breast reconstruction demand, contributes to the growth of the breast reconstruction market in the North America region.